RecruitingNot Applicable

The Effect of Magnetic Stimulation on Low Back Pain Relief and Muscle Mass Maintenance in Patients With ESRD

South Korea18 participantsStarted 2025-08-06

Plain-language summary

To determine the effectiveness of magnetic stimulation application on alleviating back pain and maintaining muscle mass in patients with end-stage renal disease.

Who can participate

Age range19 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Adults aged 19 years or older
✓. Patients diagnosed with end-stage renal failure and receiving dialysis treatment more than three times a week
✓. Back pain intensity of 4 points or higher on the visual analogue scale (VAS)
✓. Those with cognitive function that can clearly indicate NRS with a score of 23 points or higher, the criterion for determining cognitive impairment on the Mini Mental State Examination (MMSE) \[14\]
✓. Those who voluntarily decided to participate in this clinical trial after receiving a detailed explanation and fully understanding it and gave written consent to comply with the precautions

Exclusion criteria

✕. If the pain is due to trauma
✕. If it is difficult to participate in the study due to serious mental illness (e.g. schizophrenia, bipolar disorder, etc.) or psychological instability.
✕. Patients with severe neurological illness (e.g. stroke, severe dementia, etc.).
✕. Those with poor general condition due to unstable cardiovascular, digestive, respiratory, or endocrine systems, or severe internal medical illness such as systemic infection
✕. Patients participating in other therapeutic clinical trials or those who have participated in other therapeutic clinical trials within the past 30 days (observational studies are not relevant)
✕. If there are contraindications to magnetic stimulation

What they're measuring

Visual Analogue Sclae (VAS)

Timeframe: 7 days before intervention/1 day after intervention/1 month after intervention

Trial details

NCT IDNCT06982573

SponsorBundang CHA Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-02-19

Contact for this trial

Chung Eun Hye, M.S

+821032657071 a230419@chamc.co.kr

View on ClinicalTrials.gov More End-Stage Renal Disease trials